Intercellular transfer of tissue factor via the uptake of tumor-derived microvesicles

Thrombosis Research

Volumn 132, Issue 4, 2013, Pages 450-456

  Lima, Luize G ^a,b   Leal, Ana Carolina ^a   Vargas, Gabriele ^a   Porto Carreiro, Isabel ^a   Monteiro, Robson Q ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Blood coagulation; Cancer; Exosomes; Microvesicles; Tissue factor

Indexed keywords

CHROMOGENIC SUBSTRATE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; THROMBOPLASTIN;

AGGRESSIVENESS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELLULAR PARAMETERS; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERCELLULAR TRANSFER; ONCOLOGICAL PARAMETERS; PHENOTYPE; PRIORITY JOURNAL; SUPERNATANT; SURFACE PROPERTY; TUMOR DERIVED MICROVESICLE;

BLOOD COAGULATION; CANCER; EXOSOMES; FACTOR VIIA; FVIIA; MICROVESICLES; MVS; PHOSPHATIDYLSERINE; PS; TF; TISSUE FACTOR;

BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL-DERIVED MICROPARTICLES; EXOSOMES; FEMALE; HUMANS; MCF-7 CELLS; THROMBOPLASTIN;

EID: 84885174197     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.07.026     Document Type: Article

References (52)

1. C. Friend, W. Marovitz, G. Henie, W. Henie, D. Tsuei, and K. Hirschhorn Observations on cell lines derived from a patient with Hodgkin's disease Cancer Res 38 1978 2581 2591
2. G. Poste, and G.L. Nicolson Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells Proc Natl Acad Sci U S A 77 1980 399 403
3. J. Ratajczak, M. Wysoczynski, F. Hayek, A. Janowska-Wieczorek, and M.Z. Ratajczak Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication Leukemia 20 2006 1487 1495
4. A. Janowska-Wieczorek, M. Wysoczynski, J. Kijowski, L. Marquez-Curtis, B. Machalinski, and J. Ratajczak Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer Int J Cancer 113 2005 752 760
5. R. Valenti, V. Huber, M. Iero, P. Filipazzi, G. Parmiani, and L. Rivoltini Tumor-released microvesicles as vehicles of immunosuppression Cancer Res 67 2007 2912 2915
6. L.G. Lima, R. Chammas, R.Q. Monteiro, M.E. Moreira, and M.A. Barcinski Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner Cancer Lett 283 2009 168 175
7. H.F. Dvorak, S.C. Quay, N.S. Orenstein, A.M. Dvorak, P. Hahn, and A.M. Bitzer Tumor shedding and coagulation Science 212 1981 923 924
8. L.G. Lima, A.S. Oliveira, L.C. Campos, M. Bonamino, R. Chammas, and C. Werneck Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles Thromb Haemost 106 2011 712 723
9. G.J. Broze Jr. Tissue factor pathway inhibitor and the revised theory of coagulation Annu Rev Med 46 1995 103 112
10. J.L. Yu, L. May, V. Lhotak, S. Shahrzad, S. Shirasawa, and J.I. Weitz Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis Blood 105 2005 1734 1741
11. G.T. Gerotziafas, V. Galea, E. Mbemba, A. Khaterchi, M. Sassi, and H. Baccouche Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7 Thromb Res 129 2012 779 786
12. B.M. Mueller, R.A. Reisfeld, T.S. Edgington, and W. Ruf Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis Proc Natl Acad Sci U S A 89 1992 11832 11836
13. H.R. Buller, F.F. van Doormaal, G.L. van Sluis, and P.W. Kamphuisen Cancer and thrombosis: from molecular mechanisms to clinical presentations J Thromb Haemost 5 Suppl. 1 2007 246 254
14. A.A. Khorana, S.A. Ahrendt, C.K. Ryan, C.W. Francis, R.H. Hruban, and Y.C. Hu Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer Clin Cancer Res 13 2007 2870 2875
15. J.I. Zwicker, H.A. Liebman, D. Neuberg, R. Lacroix, K.A. Bauer, and B.C. Furie Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy Clin Cancer Res 15 2009 6830 6840
16. E. Bastida, A. Ordinas, G. Escolar, and G.A. Jamieson Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis Blood 64 1984 177 184
17. J.L. Yu, and J.W. Rak Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells J Thromb Haemost 2 2004 2065 2067
18. M. Davila, A. Amirkhosravi, E. Coll, H. Desai, L. Robles, and J. Colon Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation J Thromb Haemost 6 2008 1517 1524
19. G.M. Thomas, L. Panicot-Dubois, R. Lacroix, F. Dignat-George, D. Lombardo, and C. Dubois Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo J Exp Med 206 2009 1913 1927
20. K.R. Yatesa, J. Welsha, H.H. Echrisha, J. Greenmana, A. Maraveyasb, and L.A. Madden Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine Blood Coagul Fibrinolysis 22 2011 680 687
21. M.E. Tesselaar, F.P. Romijn, I.K. van der Linden, F.A. Prins, R.M. Bertina, and S. Osanto Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5 2007 520 527
22. G. Hron, M. Kollars, H. Weber, V. Sagaster, P. Quehenberger, and S. Eichinger Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer Thromb Haemost 97 2007 119 123
23. F. Langer, B. Spath, K. Haubold, K. Holstein, G. Marx, and J. Wierecky Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation Ann Hematol 87 2008 451 457
24. J. Skog, T. Wurdinger, R.S. van, D.H. Meijer, L. Gainche, and M. Sena-Esteves Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Nat Cell Biol 10 2008 1470 1476
25. J. Sahler, C. Woeller, S. Spinelli, N. Blumberg, and R. Phipps A novel method for overexpression of peroxisome proliferator-activated receptor-γ in megakaryocyte and platelet microparticles achieves transcellular signaling J Thromb Haemost 10 2012 2563 2572
26. M. Baj-Krzyworzeka, R. Szatanek, K. Weglarczyk, J. Baran, B. Urbanowicz, and P. Branski Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes Cancer Immunol Immunother 55 2006 808 818
27. K. Al-Nedawi, B. Meehan, J. Micallef, V. Lhotak, L. May, and A. Guha Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells Nat Cell Biol 10 2008 619 624
28. K. Al-Nedawi, B. Meehan, R.S. Kerbel, A.C. Allison, and J. Rak Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR Proc Natl Acad Sci U S A 106 2009 3794 3799
29. M.A. Antonyak, B. Li, L.K. Boroughs, J.L. Johnson, J.E. Druso, and K.L. Bryant Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells Proc Natl Acad Sci U S A 108 2011 4852 4857
30. C.C. Milsom, J.L. Yu, N. Mackman, J. Micallef, G.M. Anderson, and A. Guha Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis Cancer Res 68 2008 10068 10076
31. J.N. Zhou, S. Ljungdahl, M.C. Shoshan, J. Swedenborg, and S. Linder Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway Mol Carcinog 21 1998 234 243
32. T. McEachron, and N. Mackman Tumors, ticks and tissue factor J Thromb Haemost 7 2009 1852 1854
33. R. Lacroix, S. Robert, P. Poncelet, R.S. Kasthuri, N.S. Key, and F. Dignat-George Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop J Thromb Haemost 8 2010 2571 2574
34. D.L. Oliveira, C.G. Freire-de-Lima, J.D. Nosanchuk, A. Casadevall, M.L. Rodrigues, and L. Nimrichter Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions Infect Immun 78 2010 1601 1609
35. K.A. Vyas, H.V. Patel, A.A. Vyas, and R.L. Schnaar Segregation of gangliosides GM1 and GD3 on cell membranes, isolated membrane rafts, and defined supported lipid monolayers Biol Chem 382 2001 241 250
36. I. del Conde, C.N. Shrimpton, P. Thiagarajan, and J.A. Lopez Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation Blood 106 2005 1604 1611
37. J. Rak Microparticles in cancer Semin Thromb Hemost 36 2010 888 906
38. E. Cocucci, G. Racchetti, and J. Meldolesi Shedding microvesicles: artefacts no more Trends Cell Biol 19 2009 43 51
39. X. Zhang, H. Yu, J.R. Lou, J. Zheng, H. Zhu, and N. Popescu MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells J Biol Chem 286 2011 1429 1435
40. P.K. Kinnunen, and J.M. Holopainen Mechanisms of initiation of membrane fusion: role of lipids Biosci Rep 20 2000 465 482
41. F. Jansen, X. Yang, F.F. Hoyer, K. Paul, N. Heiermann, and M.U. Becher Endothelial microparticle uptake in target cells is annexin I/phosphatidylserine receptor dependent and prevents apoptosis Arterioscler Thromb Vasc Biol 32 2012 1925 1935
42. U. Rauch, D. Bonderman, B. Bohrmann, J.J. Badimon, J. Himber, and M.A. Riederer Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor Blood 96 2000 170 175
43. J. Yu, L. May, C. Milsom, G.M. Anderson, J.I. Weitz, and J.P. Luyendyk Contribution of host-derived tissue factor to tumor neovascularization Arterioscler Thromb Vasc Biol 28 2008 1975 1981
44. K.J. Svensson, P. Kucharzewska, H.C. Christianson, S. Skold, T. Lofstedt, and M.C. Johansson Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells Proc Natl Acad Sci U S A 108 2011 13147 13152
45. M. Mesri, and D.C. Altieri Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway J Biol Chem 274 1999 23111 23118
46. F. Sabatier, V. Roux, F. Anfosso, L. Camoin, J. Sampol, and F. Dignat-George Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity Blood 99 2002 3962 3970
47. N. Esumi, D. Fan, and I.J. Fidler Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor Cancer Res 51 1991 4549 4556
48. K.M. Donnelly, M.E. Bromberg, A. Milstone, J.M. Madison McNiff, G. Terwilliger, and W.H. Konigsberg Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro Thromb Haemost 79 1998 1041 1047
49. A.S. de Oliveira, L.G. Lima, A. Mariano-Oliveira, D.E. Machado, L.E. Nasciutti, and J.F. Andersen Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanoma Thromb Res 130 2012 e163 e170
50. H.H. Versteeg, F. Schaffner, M. Kerver, H.H. Petersen, J. Ahamed, and B. Felding-Habermann Inhibition of tissue factor signaling suppresses tumor growth Blood 111 2008 190 199
51. J.S. Palumbo, K.E. Talmage, J.V. Massari, C.M. La Jeunesse, M.J. Flick, and K.W. Kombrinck Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms Blood 110 2007 133 141
52. J.L. Degen, and J.S. Palumbo Hemostatic factors, innate immunity and malignancy Thromb Res 129 Suppl. 1 2012 S1 S5